Readystate Asset Management LP Bridge Bio Pharma, Inc. Transaction History
Readystate Asset Management LP
- $3.25 Trillion
- Q4 2024
A detailed history of Readystate Asset Management LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Readystate Asset Management LP holds 24,582 shares of BBIO stock, worth $863,074. This represents 0.02% of its overall portfolio holdings.
Number of Shares
24,582Holding current value
$863,074% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding BBIO
# of Institutions
320Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$887 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$882 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$529 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$437 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$217 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.2B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...